Add to ORKGeffect of memantine on survival in dementia with Lewy bodies and Parkinson’s disease with dementia: a prospective stud
OBJECTIVE: This 30-week extension trial was a continuation of the first double-blind randomized cont...
Early use of memantine in the treatment of Lewy body dementia (LBD) is a common type of major neuroc...
Contains fulltext : 57296.pdf (publisher's version ) (Closed access
To investigate the effect on survival of treatment with memantine in patients with dementia with Lew...
Objective: To determine the effect of memantine in the treatment of Dementia with Lewy Bodies (DLB)....
Aim: To investigate quality of life (QOL) and the effect of memantine treatment in patients with Lew...
Memantine protects cultured neurons from excitotoxin-induced cell-death; it attenuated loss of choli...
International audiencePrevious studies have suggested that patients with Lewy-body-related dementias...
BACKGROUND: Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) are common forms ...
Background: Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) are common forms ...
Stuart J Thomas, George T GrossbergDepartment of Neurology and Psychiatry, Saint Louis University Sc...
Objective - In both dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), attentio...
OBJECTIVE: Two common and characteristic sleep disturbances have been described in dementia with Lew...
Memantine is a relatively new drug specially developed for use in moderate-to-severe dementia. It is...
Memantine is an uncompetitive antagonist with moderate affinity for NMDA receptors, and it demonstra...
OBJECTIVE: This 30-week extension trial was a continuation of the first double-blind randomized cont...
Early use of memantine in the treatment of Lewy body dementia (LBD) is a common type of major neuroc...
Contains fulltext : 57296.pdf (publisher's version ) (Closed access
To investigate the effect on survival of treatment with memantine in patients with dementia with Lew...
Objective: To determine the effect of memantine in the treatment of Dementia with Lewy Bodies (DLB)....
Aim: To investigate quality of life (QOL) and the effect of memantine treatment in patients with Lew...
Memantine protects cultured neurons from excitotoxin-induced cell-death; it attenuated loss of choli...
International audiencePrevious studies have suggested that patients with Lewy-body-related dementias...
BACKGROUND: Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) are common forms ...
Background: Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) are common forms ...
Stuart J Thomas, George T GrossbergDepartment of Neurology and Psychiatry, Saint Louis University Sc...
Objective - In both dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), attentio...
OBJECTIVE: Two common and characteristic sleep disturbances have been described in dementia with Lew...
Memantine is a relatively new drug specially developed for use in moderate-to-severe dementia. It is...
Memantine is an uncompetitive antagonist with moderate affinity for NMDA receptors, and it demonstra...
OBJECTIVE: This 30-week extension trial was a continuation of the first double-blind randomized cont...
Early use of memantine in the treatment of Lewy body dementia (LBD) is a common type of major neuroc...
Contains fulltext : 57296.pdf (publisher's version ) (Closed access
